CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
36 hedge funds and large institutions have $9.47M invested in Carisma Therapeutics in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
22% less funds holding
Funds holding: 46 → 36 (-10)
49% less capital invested
Capital invested by funds: $18.8M → $9.47M (-$9.28M)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
36
Holding in Top 10
1
Calls
$826K
Puts
$173K
Top Buyers
| 1 | +$117K | |
| 2 | +$48.7K | |
| 3 | +$31.8K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$18K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.2K |
Top Sellers
| 1 | -$261K | |
| 2 | -$261K | |
| 3 | -$220K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$176K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$146K |